Brief: Nasdaq Accepts Evofem Plan To Regain Listing Compliance
07/04/2022 11:57
April 7 (Reuters) - Evofem Biosciences Inc EVFM.O :
* NASDAQ ACCEPTS EVOFEM PLAN TO REGAIN LISTING COMPLIANCE
Source text for Eikon: ID:nPnbHZXwYa
Further company coverage: EVFM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting